MOLECULAR ANALYSIS OF FRIEDREICH’S ATAXIA IN MACEDONIAN PATIENTS
Kocheva S1,2, Trivodalieva S1, Vlaski-Jekic S3, Kuturec M2, Efremov GD1,*
*Corresponding Author: Professor Dr. Georgi D. Efremov, Macedonian Academy of Sciences and Arts, Research Center for Genetic Engineering and Biotechnology, Aven Krste Misirkov 2, POB 428, 1000 Skopje, Republic of Macedonia; Tel: +3892-120253; Fax: +3892-115434; E-mail:gde@manu.edu
page: 61

RESULTS AND DISCUSSION

 

Representative electrophoregrams of PCR fragments from the amplification of GAA repeats in intron 1 of the frataxin gene in patients with FRDA and in healthy individuals are shown in Figure 1A and 1B, respectively. Polymerase chain reaction analyses of heterozygotes for expanded GAA alleles are shown in Figure 2. Of the 15 patients diagnosed with spinal cerebellar ataxia before 25 years of age, 14 (93.3%) were homozygous for the GAA expansion and all had two expanded alleles of same size and no detectable somatic instability. Only one patient with early onset of spinal cerebellar atax ia had two normal alleles, and this result excluded the diagnosis of FRDA. The 25 patients with late onset spinal cerebellar ataxia had two alleles in the normal size range (5-50 GAA repeats). Ten of these were heterozygotes and 15 were homozygous for normal alleles which excluded the diagnosis of FRDA.Molecular analysis of intron 1 of the frataxin gene in healthy individuals showed a range of GAA repeats from 5 to 50. Our results are concordant with already published data [1-4]. This long-range PCR protocol can be used as a diagnostic tool for FRDA and carrier detection.

Figure 1. Agarose gel electrophoresis of PCR products of intron 1 of the frataxin gene in healthy individuals (lanes 1-7) with different numbers of GAA repeats (A), and of seven patients with FRDA (lanes 1-7) (B); M: molecular weight marker.

Figure 2. Agarose gel electrophoresis of PCR products of patients (lanes 2, 5 and 6) and members of families with FRDA (lanes 1 and 3), showing the normal and expanded fragment (lanes 1 and 3); M: molecular weight marker.




Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Accepted articles
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Accepted articles
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006